×
About 748 results

ALLMedicine™ Aortitis Center

Research & Reviews  288 results

Aortic Regurgitation
https://emedicine.medscape.com/article/150490-overview:field_topic_overview_section:3:a5

Dec 7th, 2021 - Background Aortic regurgitation (AR) is the diastolic flow of blood from the aorta into the left ventricle (LV). Regurgitation is due to incompetence of the aortic valve or any disturbance of the valvular apparatus (eg, leaflets, annulus of the ao...

Aortic Regurgitation
https://emedicine.medscape.com/article/150490-print

Dec 7th, 2021 - Background Aortic regurgitation (AR) is the diastolic flow of blood from the aorta into the left ventricle (LV). Regurgitation is due to incompetence of the aortic valve or any disturbance of the valvular apparatus (eg, leaflets, annulus of the ao...

Brucella aortitis managed with debridement, extra-anatomical bypass, and long-term anti...
https://doi.org/10.1177/17085381211058572
Vascular Perry J, Alslaim H et. al.

Dec 3rd, 2021 - This report aims to review the management and outcomes of Brucella-associated mycotic aortic aneurysms. This is a retrospective chart review at a tertiary-level healthcare system. IRB approval was waived per policy. We describe a case of Brucella ...

Infective aortitis after self-expanding transcatheter valve implantation: a case report...
https://doi.org/10.1093/icvts/ivab313
Interactive Cardiovascular and Thoracic Surgery; Máximo J, Pissarra D et. al.

Nov 19th, 2021 - A 62-year-old female patient was admitted to hospital care due to an ischaemic stroke and fever of unknown origin, 6 months after a transfemoral aortic valve implantation for symptomatic aortic stenosis. Further study resulted in the diagnosis of ...

see more →

Guidelines  1 results

Consensus statement on surgical pathology of the aorta from the Society for Cardiovascu...
https://doi.org/10.1016/j.carpath.2015.05.001
Cardiovascular Pathology : the Official Journal of the So... Stone JR, Bruneval P et. al.

Jun 9th, 2015 - Inflammatory diseases of the aorta include routine atherosclerosis, aortitis, periaortitis, and atherosclerosis with excessive inflammatory responses, such as inflammatory atherosclerotic aneurysms. The nomenclature and histologic features of thes...

see more →

News  10 results

Remain Connected on Connect
https://www.mdedge.com/vascularspecialistonline/article/202603/society-news/remain-connected-connect?channel=28399

Jun 17th, 2019 - How have you managed a possible infected aortitis, a severe focal stenosis or a fractured carotid stent? Give your input in discussions about these topics, and more, on your online community, SVSConnect. If you attended VAM last week, continue the.

Four distinct IgG4-related disease groups described in study
https://www.mdedge.com/rheumatology/article/193094/lupus-connective-tissue-diseases/four-distinct-igg4-related-disease
Andrew D. Bowser

Jan 23rd, 2019 - IgG4-related disease can be grouped into four distinct clusters based on the distribution of organs involved, according to researchers who analyzed a large, multicenter cohort of patients with this heterogeneous, autoimmune-mediated condition. Dr.

FDA notifies Amgen of misbranding of its biological product, Neulasta, due to false or misleading promotional communications about the product’s benefit
http://www.fda.gov/drugs/drug-safety-and-availability/fda-notifies-amgen-misbranding-its-biological-product-neulasta-due-false-or-misleading-promotional

The Food and Drug Administration (FDA) has issued an untitled letter to Amgen Inc. for the misbranding of its biological product, Neulasta (pegfilgrastim) injection, for subcutaneous use, resulting from a false or misleading promotional communicat...

Experts Weigh In on IgG4 Disease
https://www.medpagetoday.com/rheumatology/generalrheumatology/50768

Apr 1st, 2015 - Action Points This consensus statement provides guidance for clinicians facing IgG4-related diseases, a relatively novel classification. Be aware that much of the evidence for managment of these related conditions are not informed by clinical tria...

Should IL-6 be Targeted in Vasculitis?
https://www.medpagetoday.com/rheumatology/generalrheumatology/49505

Jan 13th, 2015 - Action Points Tocilizumab may offer a treatment option for refractory giant cell arteritis, providing symptomatic relief and reductions in markers of inflammation. Note that adverse events that led to discontinuation included severe neutropenia in...

see more →